A SCIENTIST WHO TURNED his ANXIETY INTO A MISSION

KATIG didn't start with a market opportunity. It started with a baseline that wouldn't come down.

I've spent my career studying molecules. I've spent years trying to quiet the stress response in my own body. For a long time those were two separate facts about me — one lived in the lab, the other lived in my chest at 3am. The pathway I was handed was the same one everyone gets: wait, endure, escalate. It treated the episodes and ignored the resting state underneath them.

So I did what I know how to do. I read the peptide literature. I looked at signaling pathways, delivery routes, and dose-response curves — not as a patient hoping for relief, but as someone who could evaluate the mechanism. What I found was that the science had moved further than the products had.

That gap is KATIG. Not a supplement dressed up in lab language, and not a pharmaceutical that treats you as a diagnosis. A peptide formulation designed around the actual biology of the stress response, delivered in a format that respects how fast you need it to work.

I don't just understand the molecules. I understand you on a molecular level.

— Jonathan Montes, Founder & CEO of KATIG